Wockhardt unit to supply COVID-19 vaccines in U.K.


Wockhardt Ltd. will supply millions of doses of multiple COVID-19 vaccines under a deal with the U.K. government.

The production will be undertaken at the drugmaker’s CP Pharmaceuticals unit in Wrexham, North Wales. Wockhardt did not share details on the contract’s value.

Also read: COVID-19: Serum Institute gets nod for Phase 2, 3 trials of Oxford vaccine

The company has reserved fill and finish production capacity to allow for the supply of multiple vaccines to the U.K. Government. This includes AZD1222, the vaccine co-invented by the University of Oxford and its spin-out company Vaccitech and licensed by AstraZeneca.

“We have a sophisticated sterile manufacturing facility and a highly skilled workforce,” Ravi Limaye, Managing Director Wockhardt U.K. said. “We expect to start delivering the first doses of the vaccine later this year.”

Wockhardt shares jumped 10% to close at ₹303.40 on the BSE on Monday, while the broader benchmark index, the S&P BSE Sensex, declined 1.8%.

You have reached your limit for free articles this month.

To get full access, please subscribe.

Already have an account ? Sign in

Show Less Plan

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Faster pages

Move smoothly between articles as our pages load instantly.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Personalised recommendations

A select list of articles that match your interests and tastes.

Briefing

We brief you on the latest and most important developments, three times a day.

*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here